Periodic Reporting for period 1 - AAV-FACTORY (Synthetic Viral Nanosystem for Highly Efficient AAV Manufacturing for Gene Therapy)

Gene therapy is one of the most innovative and fastest growing fields in the pharmaceutical industry. The first approved gene therapy utilized a recombinant AAV vector (rAAV), and dozens of additional rAAVs for gene therapy are presently in clinical trials. rAAV gene therapy...